Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis

A preliminary study of plasma sterols

Monica Gelzo, Concetta Sica, Ausilia Elce, Antonio Dello Russo, Paola Iacotucci, Vincenzo Carnovale, Valeria Raia, Donatello Salvatore, Gaetano Corso, Giuseppe Castaldo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Low cholesterol is typically observed in the plasma of patients with cystic fibrosis (CF) contrasting with the subcellular accumulation of cholesterol demonstrated in CF cells and in mice models. However, the homeostasis of cholesterol has not been well investigated in patients with CF. Methods: We studied the plasma of 26 patients with CF and 33 unaffected controls campesterol and β-sitosterol as markers of intestinal absorption and lathosterol as a marker of de novo cholesterol biosynthesis by gas chromatography (GC-FID and GC-MS). Results: Plasma campesterol and β-sitosterol results were significantly (p = 0.01) lower while plasma lathosterol was significantly higher (p = 0.001) in patients with CF as compared to control subjects. Plasma cholesterol results were significantly lower (p = 0.01) in CF patients. Conclusions: Our data suggest that the impaired intestinal absorption of exogenous sterols in patients with CF stimulates the endogenous synthesis of cholesterol, but the levels of total cholesterol in plasma remain lower. This may be due to the CFTR dysfunction that reduces cholesterol blood excretion causing the accumulation of cholesterol in liver cells and in other tissues contributing to trigger CF chronic inflammation.

Original languageEnglish
Pages (from-to)1461-1466
Number of pages6
JournalClinical Chemistry and Laboratory Medicine
Volume54
Issue number9
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Sterols
Cystic Fibrosis
Cholesterol
Plasmas
Intestinal Absorption
Biosynthesis
Gas chromatography
Gas Chromatography
Liver
Homeostasis
Blood
Tissue
Inflammation

Keywords

  • cholesterol metabolism
  • cystic fibrosis
  • gas chromatography

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis : A preliminary study of plasma sterols. / Gelzo, Monica; Sica, Concetta; Elce, Ausilia; Dello Russo, Antonio; Iacotucci, Paola; Carnovale, Vincenzo; Raia, Valeria; Salvatore, Donatello; Corso, Gaetano; Castaldo, Giuseppe.

In: Clinical Chemistry and Laboratory Medicine, Vol. 54, No. 9, 01.09.2016, p. 1461-1466.

Research output: Contribution to journalArticle

Gelzo, M, Sica, C, Elce, A, Dello Russo, A, Iacotucci, P, Carnovale, V, Raia, V, Salvatore, D, Corso, G & Castaldo, G 2016, 'Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: A preliminary study of plasma sterols', Clinical Chemistry and Laboratory Medicine, vol. 54, no. 9, pp. 1461-1466. https://doi.org/10.1515/cclm-2015-1151
Gelzo, Monica ; Sica, Concetta ; Elce, Ausilia ; Dello Russo, Antonio ; Iacotucci, Paola ; Carnovale, Vincenzo ; Raia, Valeria ; Salvatore, Donatello ; Corso, Gaetano ; Castaldo, Giuseppe. / Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis : A preliminary study of plasma sterols. In: Clinical Chemistry and Laboratory Medicine. 2016 ; Vol. 54, No. 9. pp. 1461-1466.
@article{f2fd54b791254a56872d7dd64c7935ba,
title = "Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis: A preliminary study of plasma sterols",
abstract = "Background: Low cholesterol is typically observed in the plasma of patients with cystic fibrosis (CF) contrasting with the subcellular accumulation of cholesterol demonstrated in CF cells and in mice models. However, the homeostasis of cholesterol has not been well investigated in patients with CF. Methods: We studied the plasma of 26 patients with CF and 33 unaffected controls campesterol and β-sitosterol as markers of intestinal absorption and lathosterol as a marker of de novo cholesterol biosynthesis by gas chromatography (GC-FID and GC-MS). Results: Plasma campesterol and β-sitosterol results were significantly (p = 0.01) lower while plasma lathosterol was significantly higher (p = 0.001) in patients with CF as compared to control subjects. Plasma cholesterol results were significantly lower (p = 0.01) in CF patients. Conclusions: Our data suggest that the impaired intestinal absorption of exogenous sterols in patients with CF stimulates the endogenous synthesis of cholesterol, but the levels of total cholesterol in plasma remain lower. This may be due to the CFTR dysfunction that reduces cholesterol blood excretion causing the accumulation of cholesterol in liver cells and in other tissues contributing to trigger CF chronic inflammation.",
keywords = "cholesterol metabolism, cystic fibrosis, gas chromatography",
author = "Monica Gelzo and Concetta Sica and Ausilia Elce and {Dello Russo}, Antonio and Paola Iacotucci and Vincenzo Carnovale and Valeria Raia and Donatello Salvatore and Gaetano Corso and Giuseppe Castaldo",
year = "2016",
month = "9",
day = "1",
doi = "10.1515/cclm-2015-1151",
language = "English",
volume = "54",
pages = "1461--1466",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH",
number = "9",

}

TY - JOUR

T1 - Reduced absorption and enhanced synthesis of cholesterol in patients with cystic fibrosis

T2 - A preliminary study of plasma sterols

AU - Gelzo, Monica

AU - Sica, Concetta

AU - Elce, Ausilia

AU - Dello Russo, Antonio

AU - Iacotucci, Paola

AU - Carnovale, Vincenzo

AU - Raia, Valeria

AU - Salvatore, Donatello

AU - Corso, Gaetano

AU - Castaldo, Giuseppe

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Background: Low cholesterol is typically observed in the plasma of patients with cystic fibrosis (CF) contrasting with the subcellular accumulation of cholesterol demonstrated in CF cells and in mice models. However, the homeostasis of cholesterol has not been well investigated in patients with CF. Methods: We studied the plasma of 26 patients with CF and 33 unaffected controls campesterol and β-sitosterol as markers of intestinal absorption and lathosterol as a marker of de novo cholesterol biosynthesis by gas chromatography (GC-FID and GC-MS). Results: Plasma campesterol and β-sitosterol results were significantly (p = 0.01) lower while plasma lathosterol was significantly higher (p = 0.001) in patients with CF as compared to control subjects. Plasma cholesterol results were significantly lower (p = 0.01) in CF patients. Conclusions: Our data suggest that the impaired intestinal absorption of exogenous sterols in patients with CF stimulates the endogenous synthesis of cholesterol, but the levels of total cholesterol in plasma remain lower. This may be due to the CFTR dysfunction that reduces cholesterol blood excretion causing the accumulation of cholesterol in liver cells and in other tissues contributing to trigger CF chronic inflammation.

AB - Background: Low cholesterol is typically observed in the plasma of patients with cystic fibrosis (CF) contrasting with the subcellular accumulation of cholesterol demonstrated in CF cells and in mice models. However, the homeostasis of cholesterol has not been well investigated in patients with CF. Methods: We studied the plasma of 26 patients with CF and 33 unaffected controls campesterol and β-sitosterol as markers of intestinal absorption and lathosterol as a marker of de novo cholesterol biosynthesis by gas chromatography (GC-FID and GC-MS). Results: Plasma campesterol and β-sitosterol results were significantly (p = 0.01) lower while plasma lathosterol was significantly higher (p = 0.001) in patients with CF as compared to control subjects. Plasma cholesterol results were significantly lower (p = 0.01) in CF patients. Conclusions: Our data suggest that the impaired intestinal absorption of exogenous sterols in patients with CF stimulates the endogenous synthesis of cholesterol, but the levels of total cholesterol in plasma remain lower. This may be due to the CFTR dysfunction that reduces cholesterol blood excretion causing the accumulation of cholesterol in liver cells and in other tissues contributing to trigger CF chronic inflammation.

KW - cholesterol metabolism

KW - cystic fibrosis

KW - gas chromatography

UR - http://www.scopus.com/inward/record.url?scp=84983429286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983429286&partnerID=8YFLogxK

U2 - 10.1515/cclm-2015-1151

DO - 10.1515/cclm-2015-1151

M3 - Article

VL - 54

SP - 1461

EP - 1466

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 9

ER -